March 1, 2022 | Market Access, oncology
Download this white paper, in which we look at how market access and hospital processes will need to transform to accommodate the the influx of CAR-T therapies
With CAR-Ts continuing to take centre stage as a paradigm shift in the treatment of cancer, Tania Rodrigues investigates how market access and hospital processes will need to transform to accommodate the influx of these innovative therapies.
Download the white paper here: https://bit.ly/36T8d5j
This content was provided by Inizio
Latest Content from Inizio
Ashfield Health, part of UDG Healthcare plc, announces transformational changes including the unveiling of a new Global President, a rebrand, and the launch of two new global agencies.
Pegasus, Ashfield Digital and Creative and Cambridge Biomarketing relaunch as Mind+Matter    ‘First-in-class’ global agency conceived to confront the toughest challenges in healthcare and wellness  New global agency offers 24/7 access…
The power of a good story: Turn your insights into effective storytelling with data visualisation
How will COVID-19 affect uptake of vaccinations against other diseases?
Living With Chronic Illness (Series one)
China: How pharma can maximize success in this rapidly changing emerging market
Inhale, Exhale: The struggle of living with Severe Asthma and Severe Eosinophilic Asthma
Migraine market snapshot
Monitoring the impact of COVID-19 on the market access landscape
Digital #marcomms: How to evaluate and optimise marketing activities impacted by COVID-19
